Volunteer Assignments and Opportunities: Difference between revisions

No edit summary
Snehal.Patel (talk | contribs)
No edit summary
(7 intermediate revisions by 4 users not shown)
Line 344: Line 344:
|
|
|Jennelle Hodge (JH)/ Malini Sathanoori (MS)
|Jennelle Hodge (JH)/ Malini Sathanoori (MS)
|
|04/26/2021 -MS (re-review)
|
|
|-
|-
Line 360: Line 360:
|PENDING
|PENDING
| ||JH / MS
| ||JH / MS
|
|04/26/2021 -MS (re-review)
|
|
|-
|-
Line 400: Line 400:
|Complete
|Complete
| ||JH / MS
| ||JH / MS
|
|04/26/2021 -MS (re-review)
|
|
|-
|-
Line 417: Line 417:
|Complete
|Complete
| ||JH / MS
| ||JH / MS
|04/26/2021-MS (re-review)
|
|
|Contacted author to clarify 2 references - MS 03/02/21
|-
|-
|    Acute Myeloid Leukemia with  inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11||Disease||Christine Bryke
|    Acute Myeloid Leukemia with  inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11||Disease||Christine Bryke
Line 834: Line 834:
|
|
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma, Not  Otherwise Specified||Disease||
|    B-Lymphoblastic Leukemia/Lymphoma, Not  Otherwise Specified||Disease||Holli Drendel
|
|
|
|
|
|PENDING
| ||YA
| ||YA
|
|
Line 844: Line 844:
|B-Lymphoblastic Leukemia/Lymphoma with t(4;14)(q35.2;q32); IGH/DUX4
|B-Lymphoblastic Leukemia/Lymphoma with t(4;14)(q35.2;q32); IGH/DUX4
|Disease
|Disease
|Diana Rush
|
|
|
|
|
|PENDING
|
|
|
|YA
|YA
Line 855: Line 855:
|B-Lymphoblastic Leukemia/Lymphoma with dic(9;12)(p13;p13); PAX5/ETV6
|B-Lymphoblastic Leukemia/Lymphoma with dic(9;12)(p13;p13); PAX5/ETV6
|Disease
|Disease
|Celeste Eno
|
|
|
|
|
|PENDING
|
|
|
|YA
|YA
Line 866: Line 866:
|B-Lymphoblastic Leukemia/Lymphoma with ZNF384 Rearrangements
|B-Lymphoblastic Leukemia/Lymphoma with ZNF384 Rearrangements
|Disease
|Disease
|Helene Bruyere
|Marilena Melas
|
|
|
|
Line 899: Line 899:
|B-Lymphoblastic Leukemia/Lymphoma with dic(9;20)(p13;q11)
|B-Lymphoblastic Leukemia/Lymphoma with dic(9;20)(p13;q11)
|Disease
|Disease
|Alaa Koleilat
|
|
|
|
|
|PENDING
|
|
|
|YA
|YA
Line 908: Line 908:
|NON-WHO ENTITY
|NON-WHO ENTITY
|-
|-
|'''''T-Lymphoblastic Leukemia/Lymphoma'''''||'''''Overview'''''||
|'''''T-Lymphoblastic Leukemia/Lymphoma'''''||'''''Overview'''''||Fei Yang
|
|
|
|
|
|PENDING
| ||YA
| ||YA
|
|
|
|
|-
|-
|Early T-Cell Precursor Lymphoblastic Leukemia||Disease||
|Early T-Cell Precursor Lymphoblastic Leukemia||Disease||Fei Yang
|
|
|
|
|
|PENDING
| ||YA
| ||YA
|
|
|
|
|-
|-
|NK-Lymphoblastic Leukemia/Lymphoma||Disease||
|NK-Lymphoblastic Leukemia/Lymphoma||Disease||Fei Yang
|
|
|
|
|
|PENDING
| ||YA
| ||YA
|
|
Line 948: Line 948:
|
|
|-
|-
|Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma||Disease||Snehal Patel
|Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma||Disease||
|
|
|
|
|
|PENDING
|
|
|SP
|SP
Line 957: Line 957:
|
|
|-
|-
|       Monoclonal B-cell  Lymphocytosis||Disease||Snehal Patel
|       Monoclonal B-cell  Lymphocytosis||Disease||
|
|
|
|
|
|PENDING
|
|
|SP
|SP
Line 966: Line 966:
|
|
|-
|-
|B-cell Prolymphocytic Leukemia||Disease||Snehal Patel
|B-cell Prolymphocytic Leukemia||Disease||
|
|
|
|
|
|PENDING
|
|
|SP
|SP
Line 1,020: Line 1,020:
|
|
|-
|-
|Lymphoplasmacytic Lymphoma||Disease||Snehal Patel
|Lymphoplasmacytic Lymphoma||Disease||
|
|
|
|
|
|PENDING
|
|
|SP
|SP
Line 1,029: Line 1,029:
|
|
|-
|-
|   Waldenstrom  Macroglobulinemia||Disease||Snehal Patel
|   Waldenstrom  Macroglobulinemia||Disease||
|
|
|
|
|
|PENDING
|
|
|SP
|SP
Line 1,065: Line 1,065:
|
|
|
|
|PENDING
|Complete
| ||SP
|5/26/2021||SP
|
|
|
|
Line 1,183: Line 1,183:
|
|
|
|
|PENDING
|Complete
| ||SP
|5/28/2021||SP
|
|
|
|
Line 1,245: Line 1,245:
|
|
|9/30/20
|9/30/20
|PENDING
|Complete
| ||SP
|5/26/2021||SP
|
|
|
|